Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sare Verstockt, Bram Verstockt & Séverine Vermeire. (2019) Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD). Expert Opinion on Therapeutic Targets 23:11, pages 943-954.
Read now
Read now
Paulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi & Remo Panaccione. (2018) Clinical utility of ustekinumab in Crohn’s disease. Journal of Inflammation Research 11, pages 35-47.
Read now
Read now
Bram Verstockt, Barbara Deleenheer, Gert Van Assche, Séverine Vermeire & Marc Ferrante. (2017) A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases. Expert Opinion on Drug Safety 16:7, pages 809-821.
Read now
Read now
Articles from other publishers (21)
Ni Guo & Lu‐lu Lv. (2023) Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis. Immunity, Inflammation and Disease 11:10.
Crossref
Crossref
Chunli Hu, Shengtao Liao, Lin Lv, Chuanfei Li & Zhechuan Mei. (2023) Intestinal Immune Imbalance is an Alarm in the Development of IBD. Mediators of Inflammation 2023, pages 1-17.
Crossref
Crossref
Bram Verstockt, Azucena Salas, Bruce E. Sands, Clara Abraham, Haim Leibovitzh, Markus F. Neurath, Niels Vande Casteele, Silvio Danese, Geert D’Haens, Lars Eckmann, William A. Faubion, Brian G. Feagan, Vipul Jairath, Christopher Ma, Saurabh Mehandru, Julian Panes, Florian Rieder, William J. Sandborn, Mark S. Silverberg, Marisol Veny, Severine Vermeire & Stefania Vetrano. (2023) IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 20:7, pages 433-446.
Crossref
Crossref
Jan Korbecki, Iwona Szatkowska, Patrycja Kupnicka, Wojciech Żwierełło, Katarzyna Barczak, Iwona Poziomkowska-Gęsicka, Jerzy Wójcik, Dariusz Chlubek & Irena Baranowska-Bosiacka. (2022) The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs. International Journal of Molecular Sciences 23:13, pages 7151.
Crossref
Crossref
Vamsi Krishna, Naveen Kumar & Sugato Banerjee. (2022) Gut Microbiota and Inflammatory Disorders. Current Drug Targets 23:2, pages 156-169.
Crossref
Crossref
Kai Niu, Qifang Li, Yuan Liu, Yi Qiao, Bingbing Li, Chao Wei, Kunrui Wang, Lu’an Cui, Canlei Zheng, Rong Wang, Li Zhang, Honghua Zhang, Bing Sun & Bin Yu. (2021) Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-15.
Crossref
Crossref
Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones & Charles W. Lees. (2021) Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 14, pages 175628482110640.
Crossref
Crossref
Caroline Nothdurfter, Vladimir M. Milenkovic, Nina Sarubin, Sven Hilbert, André Manook, Johannes Weigl, Khalifa Almeqbaali, Christian H. Wetzel, Rainer Rupprecht & Thomas C. Baghai. (2019) The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder?. European Journal of Neuroscience 53:1, pages 172-182.
Crossref
Crossref
Roman Kosoy, Seunghee Kim-Schulze, Adeeb Rahman, Joshua R. Friedman, Ruiqi Huang, Lauren A. Peters, El-ad Amir, Jacqueline Perrigoue, Aleksandar Stojmirovic, Won-min Song, Hao Ke, Ryan Ungaro, Saurabh Mehandru, Judy Cho, Marla Dubinsky, Mark Curran, Carrie Brodmerkel, Eric E. Schadt, Bruce E. Sands, Jean-Frederic Colombel, Andrew Kasarskis, Carmen A. Argmann & Mayte Suárez-Fariñas. (2021) Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy. Cellular and Molecular Gastroenterology and Hepatology 12:2, pages 599-632.
Crossref
Crossref
Hadi Atabati, Seyed‐Alireza Esmaeili, Ehsan Saburi, Maedeh Akhlaghi, Amir Raoofi, Nima Rezaei & Amir Abbas Momtazi‐Borojeni. (2020) Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies. Journal of Cellular Physiology 235:12, pages 8925-8937.
Crossref
Crossref
Claire Wang, Hannah M. Baer, Daniel R. Gaya, Robert J.B. Nibbs & Simon Milling. (2019) Can molecular stratification improve the treatment of inflammatory bowel disease?. Pharmacological Research 148, pages 104442.
Crossref
Crossref
E L Nasonov. (2019) New directions of pharmacotherapy of immune - inflammatory rheumatic diseases. Terapevticheskii arkhiv 91:8, pages 98-107.
Crossref
Crossref
Jing Li, Lugen Zuo, Yun Tian, Yifan He, Zhichao Zhang, Pu Guo, Yuanyuan Ge & Jianguo Hu. (2019) Spontaneous colitis in IL‐10‐deficient mice was ameliorated via inhibiting glutaminase1. Journal of Cellular and Molecular Medicine 23:8, pages 5632-5641.
Crossref
Crossref
Bram Verstockt, Erwin Dreesen, Maja Noman, An Outtier, Nathalie Van den Berghe, Isolde Aerden, Griet Compernolle, Gert Van Assche, Ann Gils, Séverine Vermeire & Marc Ferrante. (2019) Ustekinumab Exposure-outcome Analysis in Crohn’s Disease Only in Part Explains Limited Endoscopic Remission Rates. Journal of Crohn's and Colitis 13:7, pages 864-872.
Crossref
Crossref
Jin-Mei Chen, Qing-Wei Li, Guo-Xin Jiang, Jian-Sheng Liu & Qi Cheng. (2019) IL-18 induced IL-23/IL-17 expression impairs Aβ clearance in cultured THP-1 and BV2 cells. Cytokine 119, pages 113-118.
Crossref
Crossref
E. L. Nasonov & A. M. Lila. (2019) Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects. Rheumatology Science and Practice 57:1, pages 8-16.
Crossref
Crossref
Iman Salem, Amy Ramser, Nancy Isham & Mahmoud A. Ghannoum. (2018) The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Frontiers in Microbiology 9.
Crossref
Crossref
Bram Verstockt, Marc Ferrante, Séverine Vermeire & Gert Van Assche. (2018) New treatment options for inflammatory bowel diseases. Journal of Gastroenterology 53:5, pages 585-590.
Crossref
Crossref
Ronald Anderson & Bernardo L. Rapoport. (2018) Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice. Frontiers in Oncology 8.
Crossref
Crossref
Xiaoshi Ma, Zhaolai Dai, Kaiji Sun, Yunchang Zhang, Jingqing Chen, Ying Yang, Patrick Tso, Guoyao Wu & Zhenlong Wu. (2017) Intestinal Epithelial Cell Endoplasmic Reticulum Stress and Inflammatory Bowel Disease Pathogenesis: An Update Review. Frontiers in Immunology 8.
Crossref
Crossref
Silvio Danese, Stefanos Bonovas & Laurent Peyrin-Biroulet. (2017) Positioning Ustekinumab in Crohn’s Disease: From Clinical Evidence to Clinical Practice. Journal of Crohn's and Colitis 11:10, pages 1258-1266.
Crossref
Crossref